3BX5

P38 alpha map kinase complexed with BMS-640994


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.320 
  • R-Value Work: 0.224 
  • R-Value Observed: 0.229 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor

Hynes, J.Wu, H.Pitt, S.Shen, D.R.Zhang, R.Schieven, G.L.Gillooly, K.M.Shuster, D.J.Taylor, T.L.Yang, X.McIntyre, K.W.McKinnon, M.Zhang, H.Marathe, P.H.Doweyko, A.M.Kish, K.Kiefer, S.E.Sack, J.S.Newitt, J.A.Barrish, J.C.Dodd, J.Leftheris, K.

(2008) Bioorg Med Chem Lett 18: 1762-1767

  • DOI: 10.1016/j.bmcl.2008.02.031
  • Primary Citation of Related Structures:  
    3BX5

  • PubMed Abstract: 
  • A novel structural class of p38alpha MAP kinase inhibitors has been identified via iterative SAR studies of a focused deck screen hit. Optimization of the lead series generated 6e, BMS-640994, a potent and selective p38alpha inhibitor that is orally efficacious in rodent models of acute and chronic inflammation ...

    A novel structural class of p38alpha MAP kinase inhibitors has been identified via iterative SAR studies of a focused deck screen hit. Optimization of the lead series generated 6e, BMS-640994, a potent and selective p38alpha inhibitor that is orally efficacious in rodent models of acute and chronic inflammation.


    Organizational Affiliation

    Bristol-Myers Squibb, Princeton, NJ 08543-4000, USA. john.hynes@bms.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Mitogen-activated protein kinase 14A366Homo sapiensMutation(s): 0 
Gene Names: MAPK14CSBPCSBP1CSBP2CSPB1MXI2SAPK2A
EC: 2.7.11.24
UniProt & NIH Common Fund Data Resources
Find proteins for Q16539 (Homo sapiens)
Explore Q16539 
Go to UniProtKB:  Q16539
PHAROS:  Q16539
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ16539
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
304
Query on 304

Download Ideal Coordinates CCD File 
B [auth A]N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide
C17 H22 N4 O2 S
OYOUIHFZUAKCEF-LLVKDONJSA-N
 Ligand Interaction
Binding Affinity Annotations 
IDSourceBinding Affinity
304 BindingDB:  3BX5 IC50: min: 3.5, max: 4 (nM) from 2 assay(s)
Binding MOAD:  3BX5 IC50: 3.5 (nM) from 1 assay(s)
PDBBind:  3BX5 IC50: 3.5 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.320 
  • R-Value Work: 0.224 
  • R-Value Observed: 0.229 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 65.65α = 90
b = 74.36β = 90
c = 78.98γ = 90
Software Package:
Software NamePurpose
BUSTER-TNTrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report




Entry History 

Deposition Data

  • Deposited Date: 2008-01-11 
  • Released Date: 2008-04-15 
  • Deposition Author(s): Sack, J.S.

Revision History  (Full details and data files)

  • Version 1.0: 2008-04-15
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance